Combined Nutrition and Exercise Interventions in Women With Breast Cancer History
Study of the Effects of Implementing Dietary-nutritional Strategies and an Exercise Program at the Physical, Physiological, and Psychological Level in Women With a History of Breast Cancer.
1 other identifier
interventional
120
1 country
1
Brief Summary
This study aims to evaluate the effects of a combined dietary-nutritional and physical exercise intervention on physical, physiological, and psychological outcomes in women who are breast cancer survivors. Participants will be randomly assigned to different intervention groups involving dietary modification, exercise training, or their combination, compared to a control group. The program will last 12 weeks and will include pre- and post-intervention assessments of body composition, metabolic parameters, functional capacity, and quality of life. The primary goal is to assess improvements in physical fitness, body composition, and emotional well-being, as well as to identify potential synergistic effects of combined interventions in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 25, 2025
CompletedFirst Posted
Study publicly available on registry
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedFebruary 4, 2026
February 1, 2026
2.3 years
November 25, 2025
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Fat-Free Mass (kg)
To evaluate changes in fat-free mass after the 12-week intervention, measured by bioimpedance analysis (BIODY XPERT ZM).
Baseline and Week 12
Secondary Outcomes (21)
Change in Fat Mass (%)
Baseline and Week 12
Change in Body Weight (kg)
Baseline and Week 12
Change in Body Mass Index (kg/m²)
Baseline and Week 12
Change in Waist Circumference (cm)
Baseline and Week 12
Change in Handgrip Strength (kg)
Baseline and Week 12
- +16 more secondary outcomes
Study Arms (6)
Arm 1 - Control Group
NO INTERVENTIONParticipants will not receive any specific dietary or exercise intervention. They will be asked to maintain their usual lifestyle and dietary habits during the 12-week study period. General health recommendations based on national guidelines will be provided at baseline.
Arm 2 - Mediterranean Diet Group (MD)
EXPERIMENTALParticipants will receive individualized nutritional counseling promoting adherence to a Mediterranean dietary pattern, emphasizing fruits, vegetables, legumes, whole grains, olive oil, nuts, fish, and moderate dairy intake. Processed and high-sugar foods will be limited. Dietitians will provide personalized follow-up and adjustments every two weeks to ensure adherence.
Arm 3 - Strength Training Group (ST)
EXPERIMENTALParticipants will perform a 12-week supervised resistance training program focused on improving muscular strength and functional capacity. Sessions will be conducted three times per week, lasting approximately 60 minutes, and include major muscle groups using elastic bands, free weights, and bodyweight exercises. Training load will progressively increase according to individual capacity.
Arm 4 - Endurance Training Group (ET)
EXPERIMENTALParticipants will follow a structured aerobic exercise program consisting of walking, cycling, or treadmill sessions three times per week for 12 weeks. The intensity will be moderate (60-75% of estimated maximal heart rate), gradually progressing as tolerated. The goal is to enhance cardiorespiratory fitness and overall endurance.
Arm 5 - Combined Training Group (CT)
EXPERIMENTALParticipants will perform both strength and aerobic training during the 12-week intervention. Each session (3 per week, 60-70 minutes) will include resistance exercises targeting major muscle groups followed by aerobic activity at moderate intensity. The program aims to improve both muscular and cardiovascular performance synergistically.
Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)
EXPERIMENTALParticipants will simultaneously receive the Mediterranean Diet counseling and participate in the Combined Training program for 12 weeks. The objective is to assess the synergistic effects of diet and exercise on physical, physiological, and psychological health in breast cancer survivors.
Interventions
Individualized nutritional counseling based on Mediterranean diet principles, emphasizing the intake of fruits, vegetables, legumes, whole grains, nuts, olive oil, and fish, while reducing red meat, processed foods, and added sugars. Sessions will be held biweekly to ensure adherence and promote long-term dietary behavior change.
A structured resistance exercise program performed three times per week for 12 weeks. Each 60-minute session will include exercises for major muscle groups using elastic bands, dumbbells, or body weight, progressively increasing intensity to improve muscle strength and endurance.
A structured aerobic exercise program consisting of walking, cycling, or treadmill training three times per week for 12 weeks. Exercise intensity will range from 60% to 75% of the estimated maximal heart rate, progressively adjusted to enhance cardiovascular fitness and fatigue resistance.
A combined exercise protocol including both resistance and aerobic components within each 60-70-minute session, three times per week for 12 weeks. Strength exercises will precede moderate-intensity aerobic work to improve overall physical performance and functional capacity.
Comprehensive lifestyle intervention combining Mediterranean diet counseling with the supervised combined training program. Participants will receive individualized diet plans and attend three supervised exercise sessions per week. The intervention targets improvements in body composition, physical fitness, and emotional well-being.
Eligibility Criteria
You may qualify if:
- Women aged 30 to 65 years.
- Previous diagnosis of breast cancer (stages I-III) confirmed by medical records.
- Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment.
- Absence of active cancer or evidence of recurrence.
- Medical clearance to perform physical exercise.
- Willingness to participate in dietary and/or exercise interventions for 12 weeks.
- Ability to attend evaluation and intervention sessions and comply with study procedures.
- Signed written informed consent.
You may not qualify if:
- Active cancer, metastasis, or ongoing chemotherapy or radiotherapy.
- Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise.
- Musculoskeletal or neurological conditions limiting participation in physical activity.
- Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention.
- Current participation in another clinical trial or structured lifestyle intervention.
- Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period.
- Pregnancy, breastfeeding, or intention to become pregnant during the study.
- Inability to comply with the intervention schedule or follow-up assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
European Institute Of Exercise and Health
Elche, Alicante, 03203, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Health Sciences
Study Record Dates
First Submitted
November 25, 2025
First Posted
December 10, 2025
Study Start
September 1, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02